QA: Sarepta Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000873303_2019_Sarepta_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000873303, Sarepta Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,426,183,000
1 IntangibleAssetsNetIncludingGoodwill 11,574,000
2 PropertyPlantAndEquipmentNet 97,024,000
3 remainder_Assets 107,294,000
4 LiabilitiesCurrent 173,690,000
5 LiabilitiesNoncurrent 15,555,000
6 remainder_Liabilities 420,554,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 323,820,894
9 ResearchAndDevelopmentExpense 403,417,315
10 remainder_Expenses 34,827,199
11 remainder_Revenues 1,025,434,979
12 remainder_NetIncome 122,639,063
13 remainder_ComprehensiveNetIncome -258,669
  yvar yval
0 Assets 1,642,075,000
1 Liabilities 609,799,000
2 Expenses 762,065,408
3 Revenues 1,025,434,979
4 StockholdersEquity 1,032,276,000
5 NetIncome 386,008,634
6 ComprehensiveNetIncome 385,879,300
7 BaseVar 2,081,136,060
8 EconomicCapitalRatiobeforeLimitedLiability 2.34
9 EconomicCapitalRatio 3.25

Edgar->Model Mapping

Feature Distribution

Change over Time